Marquardt addresses cause for medical suspension, UFC termination
June 28, 2011
The MMA Hour interviewed Nate Marquardt three days after being fired by the UFC when he was scratched from the main event of UFC on Versus 4 for undisclosed reasons. Marquardt explained on Tuesday that he had high levels of testosterone causing the Pennsylvania state athletic commission to suspend him.
Marquardt was recommended Hormone Replacement Therapy for low testosterone levels which caused the high levels of testosterone.
Via MMA Fighting:
Looking back, Marquardt, who cried at two different points of the interview, regrets several actions that may or may not have contributed to the problem. One thing he pointed out was that several years ago, he regularly took androstenediol, a popular supplement that was sold over-the-counter at nutrition shops until being reclassified as a steroid in 2005 and banned. Marquardt said he took the supplement for several years and wonders if it could have compromised his system and led to low testosterone production.
It is interesting that Marquardt’s team waited three days before announcing this information. While I understand that the MMA Hour is the best forum to address these issues, there could have been another sit down interview or press conference after it was announced that he was terminated. At that point, it would make sense to get his story out prior to internet rumors. On another note, the fact that Marquardt’s camp contends they did not know he was fired until they read it on twitter is unprofessional on the part of the UFC. Marquardt is a veteran of the UFC and despite the allegations, should have been told personally.
Despite the way he was discarded, the appearance on Tuesday’s show may be an act of contrition. From all accounts Marquardt was genuinely sorry and owned up to his mistakes. Unlike Chael Sonnen, he did not attack the commission or provide an excuse. Yet, he was fired. Perhaps this self-humiliation is penance for which the UFC will grant mercy in hopes of coming back in the future.